Covidien Limited (COV)
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Richard J. Meelia, CEO/Director/President
131 Front Street
Hamilton
, HM 12
BU
Map it ![]()
Phone: (441) 298-2480
Fax:
Overview
The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.
Portfolio Articles
-
Have a Seat
Ever since Enron's downfall and the introduction of Sarbanes-Oxley, corporate boards have taken on a less clubby air -- presenting opportunities for first-timers.
May 02 2008
News Feeds
-
Midday Glance: Health Care Equipment companies
AP
Oct 10 2008
-
Early Glance: Health Care Equipment companies
AP
Oct 10 2008
-
Final Glance: Health Care Equipment companies
AP
Oct 09 2008
-
Covidien names Meelia chairman of the board
AP
Sep 29 2008
-
Covidien declares quarterly dividend
AP
Sep 29 2008
-
Covidien will begin restructuring program
AP
Sep 29 2008
-
Covidien warns of leukemia risks with Phosphocol
AP
Sep 18 2008
Press Releases
-
Covidien Introduces Permacol(TM) Biologic Implant Oct-09-2008, 09:00AM EDT
-
Covidien Launches Hernia Website to Educate Public About Solutions for Inguinal Hernia Repair Oct-07-2008, 09:00AM EDT
-
Covidien Introduces the SprayShield(TM) Adhesion Barrier System to the European Marketplace Oct-02-2008, 09:00AM EDT
-
Covidien CEO Elected Chairman of the Board Sep-29-2008, 04:21PM EDT
News From Around the Web
News
-
'It's choking the lifeline'
(Boston Globe)Oct 12 2008 -
Our Favorite Health-Care Safe Havens
(Morningstar)Oct 10 2008 -
Midday Glance: Health Care Equipment companies
(Boston Globe)Oct 10 2008 -
Final Glance: Health Care Equipment companies
(Businessweek)Oct 09 2008 -
Oct 09 2008
-
Citi Maintains a 'Buy' Rating on Medical Technology Stocks, But Lowers Price Targets
(StreetInsider)Oct 09 2008 -
Covidien Introduces Permacol(TM) Biologic Implant
(Genetic Engineering News)Oct 09 2008
Employees
Number of Employees: 43,800
Revenue per Employee: $232,192
Top Executives
Kevin G. DaSilva, Director/Vice President/Treasurer
John H. Masterson, Director/General Counsel/Senior VP
Jose E. Almeida, Senior VP/President, Divisional
Charles J. Dockendorff, Executive VP/CFO/Director
Richard G. Brown, Jr., Chief Accounting Officer/Vice President/Controller
Karen A. Quinn-Quintin, Senior VP, Divisional
Amy A. McBride-Wendell, Senior VP, Divisional
Timothy R. Wright, President, Divisional/Senior VP
Eric C. Green, Vice President/Other Executive Officer
Board of Directors
Kevin G. DaSilva, Director/Vice President/Treasurer
Craig Arnold, Director
Dennis H. Reilley, Chairman of the Board/Director
Randall J. Hogan, Director
Eric C. Green, Vice President/Other Executive Officer
Joseph A. Zaccagnino, Director
Christopher J. Coughlin, Director
John H. Masterson, Director/General Counsel/Senior VP
John M. Connors, Jr., Director
Financials
Quarterly
Annual
| Income Statement | 08/2008 | 05/2008 | 02/2008 | 12/2007 |
|---|---|---|---|---|
| Sales | 1.2 Bil. | 1.06 Bil. | 1.08 Bil. | 1.22 Bil. |
| Gross Operating Profit | 1.39 Bil. | 1.37 Bil. | 1.24 Bil. | 1.39 Bil. |
| Operating Income before D & A (EBITDA) | 559 Mil. | 596 Mil. | 472 Mil. | 612 Mil. |
| Total Income Before Interest Expenses (EBIT) | 552 Mil. | 416 Mil. | 647 Mil. | 179 Mil. |
| Total Net Income | 393 Mil. | 235 Mil. | 470 Mil. | 34 Mil. |
| Basic EPS, Total | 0.78 | 0.47 | 0.94 | 0.07 |
| Diluted EPS, Total | 0.77 | 0.46 | 0.94 | 0.07 |
| BALANCE STATEMENT | 08/2008 | 05/2008 | 02/2008 | 12/2007 |
|---|---|---|---|---|
| Cash and Equivalents | NA | 849 Mil. | NA | 872 Mil. |
| Total Assets | NA | 5.37 Bil. | NA | 7.56 Bil. |
| Total Liabilities | NA | 2 Bil. | NA | 5.37 Bil. |
| Total Capitalization | NA | 10.99 Bil. | NA | 10.31 Bil. |
| Cash Flow | 08/2008 | 05/2008 | 02/2008 | 12/2007 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | -462 Mil. | NA | 2.2 Bil. |
| Net Cash From Investing Activities | NA | 992 Mil. | NA | -1.71 Bil. |
| Net Cash From Financing Activities | NA | -627 Mil. | NA | 110 Mil. |
| Net Change in Cash & Cash Equivalents | NA | -23 Mil. | NA | 630 Mil. |
| Income Statement | 2007 |
|---|---|
| Sales | 4.92 Bil. |
| Gross Operating Profit | 5.25 Bil. |
| Operating Income before D & A (EBITDA) | 2.44 Bil. |
| Total Income Before Interest Expenses (EBIT) | 339 Mil. |
| Total Net Income | -332 Mil. |
| Basic EPS, Total | -0.67 |
| Diluted EPS, Total | -0.67 |
| BALANCE STATEMENT | 2007 |
|---|---|
| Cash and Equivalents | 872 Mil. |
| Total Assets | 7.56 Bil. |
| Total Liabilities | 5.37 Bil. |
| Total Capitalization | 10.31 Bil. |
| Cash Flow | 2007 |
|---|---|
| Net Cash From Continuing Operations | 2.2 Bil. |
| Net Cash From Investing Activities | -1.71 Bil. |
| Net Cash From Financing Activities | 110 Mil. |
| Net Change in Cash & Cash Equivalents | 630 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
21.14 Bil.
17.65 Bil.
27.26 Bil.
9.34 Bil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- To request a change please click here
Also in Portfolio.com
Most Read
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.





